KenarJhaveri United StatesNorthwell Health

Kenar Jhaveri, MD is a Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell and Associate Chief of Nephrology at Northwell health, NY. He is a leader in glomerular diseases and onconephrology. He is currently the editor in chief of ASN Kidney News.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/39820a8d22df4375d3473ce267a804eb.jpg

First name

Kenar

Last name

Jhaveri

Institution

Country

United States

Friday, February 7, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course IK01 GeorgiAbraham Chair IndiaMGM Healthcare, Chennai, India KriangTungsanga Chair ThailandDepartment of Medicine, Faculty of Medicine, Chulalongkorn Unviersity SanjayD'Cruz Chair IndiaGovernment Medical College & Hospital, Chandigarh Renal Complications of Novel Cancer Therapies: Practical Insights IK01-01 AnushreeShirali Speaker United StatesYale University Immune Checkpoint Inhibitors and AKI IK01-02 MitchellRosner Speaker United StatesUniveristy of Virginia Health Electrolyte Abnormalities in the Cancer Patient IK01-03 JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland Opening an Onconephrology Clinic - What Should You Be Aware of? IK01-04 KenarJhaveri Speaker United StatesNorthwell Health Q&A IK01-05 Amaltas Hall B101-A

Time

Session

9:45 a.m.

11:15 a.m.

Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course

IK01

GeorgiAbraham Chair IndiaMGM Healthcare, Chennai, India

KriangTungsanga Chair ThailandDepartment of Medicine, Faculty of Medicine, Chulalongkorn Unviersity

SanjayD'Cruz Chair IndiaGovernment Medical College & Hospital, Chandigarh

Renal Complications of Novel Cancer Therapies: Practical Insights

IK01-01

AnushreeShirali Speaker United StatesYale University
Immune Checkpoint Inhibitors and AKI

IK01-02

MitchellRosner Speaker United StatesUniveristy of Virginia Health
Electrolyte Abnormalities in the Cancer Patient

IK01-03

JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland
Opening an Onconephrology Clinic - What Should You Be Aware of?

IK01-04

KenarJhaveri Speaker United StatesNorthwell Health
Q&A

IK01-05

Amaltas Hall B101-A

Thursday, February 6, 2025

Time	Session

9 a.m. 11 a.m.	Annual Review of Nephrology Course: Managing Kidney Failure NAR1 KenarJhaveri Chair United StatesNorthwell Health MitchellRosner Chair United StatesUniveristy of Virginia Health New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors NAR1-01 JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals NAR1-02 KrishnaswamySampathkumar Speaker IndiaMeenakshi Mission Hospital Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue? NAR1-03 Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore Q and A NAR1-04 Neelkamal Hall 305
11:30 a.m. 1:30 p.m.	Annual Review of Nephrology Course: Best Practices in Diabetic Kidney Disease Care NAR2 KenarJhaveri Chair United StatesNorthwell Health MitchellRosner Chair United StatesUniveristy of Virginia Health Clinical Trials Overview: Focus on GLP1a, MRA, and SGLT2 NAR2-01 MaartenTaal Speaker United KingdomUniversity of Nottingham SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach NAR2-02 KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach NAR2-03 MadhukarMisra Speaker United StatesUniversity of Missouri Columbia, USA Q and A NAR2-04 Neelkamal Hall 305
2:15 p.m. 4:15 p.m.	Annual Review of Nephrology Course: Electrolyte Management in the ICU NAR3 KenarJhaveri Chair United StatesNorthwell Health MitchellRosner Chair United StatesUniveristy of Virginia Health Approaches to the Patient with Severe Hyponatremia and Acute Kidney Injury NAR3-01 MitchellRosner Speaker United StatesUniveristy of Virginia Health Approaches to Severe Hypercalcemia NAR3-02 KenarJhaveri Speaker United StatesNorthwell Health Approaches to Severe Hyperkalemia NAR3-03 KSNayak Speaker IndiaVirinchi Hospitals Q and A NAR3-04 Neelkamal Hall 305